Immunovant (IMVT) EBITDA (2019 - 2026)
Immunovant's EBITDA came in at -$153.13 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$119.59 million a year earlier.
Powered by 
Analysis
Immunovant (IMVT) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immunovant reported EBITDA of -$538.52 million; for FY2026 (ended Mar 31, 2026), it came in at -$504.98 million.
- Going back by fiscal year, EBITDA was -$412.57 million in FY2025, -$258.54 million in FY2024, -$210.76 million in FY2023 and -$156.69 million in FY2022.
- The fiscal Q1 2027 figure represents the lowest quarterly EBITDA in data going back to fiscal Q4 2019.
- Business Quant data shows IMVT's EBITDA at -$150.6 million (Q4 2026), -$108.98 million (Q3 2026) and -$125.8 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Immunovant | 7.32 Bn | 4.11 Bn | - | -153.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -153.13 Mn |
| Mar 31, 2026 | -150.60 Mn |
| Dec 31, 2025 | -108.98 Mn |
| Sep 30, 2025 | -125.80 Mn |
| Jun 30, 2025 | -119.59 Mn |
| Mar 31, 2025 | -105.76 Mn |
| Dec 31, 2024 | -110.87 Mn |
| Sep 30, 2024 | -108.95 Mn |
| Jun 30, 2024 | -86.99 Mn |
| Mar 31, 2024 | -75.02 Mn |
| Dec 31, 2023 | -51.47 Mn |
| Sep 30, 2023 | -58.15 Mn |
| Jun 30, 2023 | -73.90 Mn |
| Mar 31, 2023 | -60.37 Mn |
| Dec 31, 2022 | -62.79 Mn |
| Sep 30, 2022 | -47.62 Mn |
| Jun 30, 2022 | -39.98 Mn |
| Mar 31, 2022 | -47.14 Mn |
| Dec 31, 2021 | -41.35 Mn |
| Sep 30, 2021 | -37.71 Mn |
API Access
Immunovant EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();